Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05520801
What this trial is testing

Primary Hepatobiliary Cancer Cohort of Central China

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Neoplasms
Tongji Hospital 2,000
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Testing effectiveness (Phase 2)Study completedNCT03510871
What this trial is testing

Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan 43
Testing effectiveness (Phase 2)UnknownNCT05555316
What this trial is testing

TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma

Who this might be right for
Liver Tumor
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07518706
What this trial is testing

Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT03722498
What this trial is testing

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT00039078
What this trial is testing

Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Allan Tsung
Not applicableUnknownNCT05202015
What this trial is testing

Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study

Who this might be right for
HCCHepatocellular CarcinomaMRI
Charite University, Berlin, Germany 150
Not applicableActive Not RecruitingNCT05128123
What this trial is testing

Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 1,600
Not applicableLooking for participantsNCT05994859
What this trial is testing

SIRT for Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 35
Early research (Phase 1)Study completedNCT03175679
What this trial is testing

Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 10
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Not applicableStudy completedNCT06626724
What this trial is testing

A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.

Who this might be right for
Hepatocellular Carcinoma (HCC)DGF
Jian You 131
Not applicableStudy completedNCT05178524
What this trial is testing

Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

Who this might be right for
Gut MicrobiotaHepatocellular CarcinomaBifidobacterium
Tongji Hospital 180
Large-scale testing (Phase 3)Ended earlyNCT02460991
What this trial is testing

ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cell Carcinoma
Boston Scientific Corporation 2
Not applicableUnknownNCT03652896
What this trial is testing

Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
Huazhong University of Science and Technology 60
Post-approval studies (Phase 4)Active Not RecruitingNCT03024684
What this trial is testing

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

Who this might be right for
HepatoCellular Carcinoma
Chiayi Christian Hospital 240
Testing effectiveness (Phase 2)WithdrawnNCT02406508
What this trial is testing

Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Delcath Systems Inc.
Testing effectiveness (Phase 2)WithdrawnNCT01669668
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Carcinoma, Hepatocellular
Washington University School of Medicine
Next Page